Evidence map›Paper›PMID 42513147›Full record

ReviewMolecules (Basel, Switzerland)2026

Research Progress on Nicotine Control Methods in Tobacco Products.

Xu Xu, Haoxuan Song, Shuaiyu Chen, Yu Wang, Hong Ye

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xu XuResearch Center for Innovative Applications in Health Security, Beijing Technology and Business University, Beijing 100048, China.
Haoxuan SongKey Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing 100048, China.
Shuaiyu ChenResearch Center for Innovative Applications in Health Security, Beijing Technology and Business University, Beijing 100048, China.
Yu WangSchool of Advanced Materials and Future Technologies, Beijing Technology and Business University, Beijing 100048, China.
Hong YeKey Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing 100048, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper systematically reviews recent research progress on nicotine control methods in tobacco products, with a focus on various strategies including the regulation of internal tobacco components (such as organic acids, pH, polyols, and moisture content) and the application of external functional materials (e.g., bacterial cellulose-based sustained-release systems and MOF composites). The mechanisms and control efficacy of these approaches are elaborated, along with a comparative analysis of their applicable conditions and limitations. Furthermore, emerging research directions in the precise control of nicotine release are discussed, including multi-factor coupling regulation, material structure design, and release kinetic modeling. By systematically examining the strengths and weaknesses of existing technologies, product-specific and condition-dependent internal control strategies are summarized for different tobacco products based on the available evidence. Finally, future prospects are outlined, including the development of intelligent sustained-release materials, the construction of multi-path synergistic regulation systems, and the integration of toxicological assessments to achieve comprehensive optimization of product quality and health risks. This review aims to provide a mechanistic basis for the rational design of nicotine release control strategies in tobacco products.

Indexed as

NicotineTobacco ProductsDelayed-Action PreparationsHumansDelayed-Action PreparationsNicotinecontrolled releasenicotinetobacco products

Identifiers

PMID42513147
PMCPMC13414380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.